Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort

BACKGROUND: European data indicate that systemic sclerosis (SSc)-related death rates are increasing, thus raising concerns about SSc’s optimal management. Herein, we describe current treatment modalities and drug survival in a real-life SSc cohort. METHODS: Details on immunosuppressive/antiprolifera...

Descripción completa

Detalles Bibliográficos
Autores principales: Panopoulos, S., Chatzidionysiou, Κ., Tektonidou, M. G., Bournia, V. K., Drosos, A. A., Liossis, Stamatis-Nick C., Dimitroulas, T., Sakkas, L., Boumpas, D., Voulgari, P. V., Daoussis, D., Thomas, K., Georgiopoulos, G., Vosvotekas, G., Garyfallos, Α., Sidiropoulos, P., Bertsias, G., Vassilopoulos, D., Sfikakis, P. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092571/
https://www.ncbi.nlm.nih.gov/pubmed/32293545
http://dx.doi.org/10.1186/s13075-020-2140-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092571/
https://www.ncbi.nlm.nih.gov/pubmed/32293545
http://dx.doi.org/10.1186/s13075-020-2140-3

Ejemplares similares